Palliative Care and Oncology Survey on Terminology
POST
What do Individuals Known to Palliative Care and Oncology Services Think About the Terminology Used to Describe Them?
1 other identifier
observational
1,532
2 countries
3
Brief Summary
The term '"cancer survivors" is widely used but has different definitions. One definition describes "cancer survivors" as individuals from the time of diagnosis throughout their lives, which includes people living with cancer and people free of cancer. The views of some groups included in this definition of "cancer survivors" have rarely been assessed, including those with cancer on anticancer treatment and those known to palliative care. How they view these terms could have important implications for how they receive care services. This is an international multi-centre observational study. It aims to recruit patients internationally across Ireland and the United Kingdom. Participants known to cancer and/or palliative care hospital or hospice services as inpatients, outpatients or community patients will be asked to complete a survey during a one-off visit which should last under 30 minutes. The survey asks a series of questions to determine the perceptions of patients know to cancer and palliative care services about the terminologies used to describe them.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Oct 2023
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 11, 2023
CompletedFirst Posted
Study publicly available on registry
May 23, 2023
CompletedStudy Start
First participant enrolled
October 3, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2025
CompletedJune 27, 2025
June 1, 2025
2 years
May 11, 2023
June 23, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The proportion of individuals with cancer known to palliative care services (Group 1) and the proportion of individuals on anti-cancer treatment (Group 2) that would "moderately dislike" or "strongly dislike" being described as a cancer survivor.
The proportion of individuals with cancer throughout the study known to palliative care services (Group 1), and the proportion of individuals with cancer throughout the study on anti-cancer treatment (Group 2), that would "moderately dislike" or "strongly dislike" being described as a cancer survivor. This is not assessing change between two time points in the study, but determining this outcome for the two Groups throughout the whole study.
at study completion, an average of 1 year
Secondary Outcomes (7)
The proportions of these groups (Group 1 and Group 2) that "moderately dislike" or "strongly dislike" being described as a patient, client, consumer, customer, service user, cancer patient, patient with cancer, and person living with cancer.
at study completion, an average of 1 year
The proportion of these groups (Group 1 and Group 2) that think the specific subgroups of patients with cancer should be known as "cancer survivors":
at study completion, an average of 1 year
The proportion of these groups (Group 1 and Group 2) that "moderately dislike" or "strongly dislike" the widely used definition of "cancer survivor".
at study completion, an average of 1 year
Any association between perception towards the term cancer survivor and phase of cancer illness, cancer diagnosis and performance status.
at study completion, an average of 1 year
Any association between perception towards the term cancer survivor and personal demographic details including country of residence, age, gender, marital status, educational attainment, and ethnicity.
at study completion, an average of 1 year
- +2 more secondary outcomes
Study Arms (2)
Group 1
Individuals with a diagnosis of cancer known to palliative care services. This group completes Case Report Form for Group 1.
Group 2
Individuals with a diagnosis of cancer receiving anti-cancer treatment known to oncology services. This group completes Case Report Form for Group 2
Interventions
Each group receives a survey to complete. The only difference between the two is the inclusion criteria; the surveys are the same.
Eligibility Criteria
Patients known to hospice inpatient units, community palliative care services, hospital palliative care teams and/or oncology services at specified hospices and cancer centres internationally will be invited to participate. Participants may be inpatients, outpatients or community patients associated with the study sites. Participants must meet all of the inclusion criteria for the study, and none of the exclusion criteria for the study. Convenience sampling will be undertaken. Potential participants will be identified by the clinical team. The clinical team will ask them if they would be interested in taking part in a study. If they agree, the research team will arrange to meet with the patient.
You may qualify if:
- Diagnosis of cancer
- Under the care of palliative care services as an inpatient, outpatient or community patient
- Age ≥18 years
- Able to speak / read English (enough to complete questionnaire)
You may not qualify if:
- Unable to provide consent
- Unable to complete questionnaire
- Group 2: Individuals with a diagnosis of cancer receiving anti-cancer treatment known to oncology services
- Diagnosis of cancer
- Under the care of oncology services and currently receiving an anticancer treatment regimen of any kind
- Age ≥18 years
- Able to speak / read English (enough to complete questionnaire)
- Unable to provide consent
- Unable to complete questionnaire
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (3)
St Vincent's University Hospital
Dublin, County Dublin, D04 T6F4, Ireland
Our Lady's Hospice & Care Services
Dublin, D6W RY72, Ireland
Royal Surrey County Hospital
Guildford, Surrey, GU2 7XX, United Kingdom
Related Publications (5)
Cheung SY, Delfabbro P. Are you a cancer survivor? A review on cancer identity. J Cancer Surviv. 2016 Aug;10(4):759-71. doi: 10.1007/s11764-016-0521-z. Epub 2016 Feb 11.
PMID: 26868682BACKGROUNDCosta DSJ, Mercieca-Bebber R, Tesson S, Seidler Z, Lopez AL. Patient, client, consumer, survivor or other alternatives? A scoping review of preferred terms for labelling individuals who access healthcare across settings. BMJ Open. 2019 Mar 7;9(3):e025166. doi: 10.1136/bmjopen-2018-025166.
PMID: 30850410BACKGROUNDMarzorati C, Riva S, Pravettoni G. Who Is a Cancer Survivor? A Systematic Review of Published Definitions. J Cancer Educ. 2017 Jun;32(2):228-237. doi: 10.1007/s13187-016-0997-2.
PMID: 26854084BACKGROUNDRadbruch L, De Lima L, Knaul F, Wenk R, Ali Z, Bhatnaghar S, Blanchard C, Bruera E, Buitrago R, Burla C, Callaway M, Munyoro EC, Centeno C, Cleary J, Connor S, Davaasuren O, Downing J, Foley K, Goh C, Gomez-Garcia W, Harding R, Khan QT, Larkin P, Leng M, Luyirika E, Marston J, Moine S, Osman H, Pettus K, Puchalski C, Rajagopal MR, Spence D, Spruijt O, Venkateswaran C, Wee B, Woodruff R, Yong J, Pastrana T. Redefining Palliative Care-A New Consensus-Based Definition. J Pain Symptom Manage. 2020 Oct;60(4):754-764. doi: 10.1016/j.jpainsymman.2020.04.027. Epub 2020 May 6.
PMID: 32387576BACKGROUNDWee M, Dau H, Gastonguay L, De Vera MA. How do individuals with colorectal cancer perceive the term "cancer survivor": a cross-sectional survey. J Cancer Surviv. 2022 Apr;16(2):257-268. doi: 10.1007/s11764-021-01015-9. Epub 2021 Mar 11.
PMID: 33709303BACKGROUND
Related Links
MeSH Terms
Conditions
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Andrew N Davies, MBBS MSc MD
Our Lady's Hospice & Care Services
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor Andrew Davies
Study Record Dates
First Submitted
May 11, 2023
First Posted
May 23, 2023
Study Start
October 3, 2023
Primary Completion
October 1, 2025
Study Completion
October 1, 2025
Last Updated
June 27, 2025
Record last verified: 2025-06